Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany

EQ-5D health state utilities (HSU) are commonly used in health economics to compute quality-adjusted life years (QALYs). The EQ-5D, which is country-specific, can be derived directly or by mapping from self-reported health-related quality of life (HRQoL) scales such as the PROMIS-29 profile.

In this article, the authors sought to find optimal models predicting the EQ-5D-5L crosswalk from the PROMIS-29 in the United Kingdom, France, and Germany and compared the prediction performances with that of a US model.

To read the full research article, click here.


Aims and scope

Health and Quality of Life Outcomes considers original manuscripts on the Health-Related Quality of Life (HRQOL) assessment for evaluation of medical and psychosocial interventions. It also considers approaches and studies on psychometric properties of HRQOL and patient reported outcome measures, including cultural validation of instruments if they provide information about the impact of interventions. The journal publishes study protocols and reviews summarising the present state of knowledge concerning a particular aspect of HRQOL and patient reported outcome measures. Reviews should generally follow systematic review methodology. Comments on articles and letters to the editor are welcome.

Sign up to receive article alerts

Health and Quality of Life Outcomes is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Editor profiles

Mark Oremus, co-Editor-in-Chief

Dr Mark Oremus is an Associate Professor in the School of Public Health and Health Systems at the University of Waterloo, Canada. He holds a PhD in Epidemiology and Biostatistics from McGill University.

Dr Oremus' primary research interests include aging and chronic disease, cognition, dementia, and Alzheimer’s disease. He has conducted studies on willingness-to-pay for Alzheimer’s disease medications, measuring quality-of-life in Alzheimer’s disease, and the use of outcome measurement instruments in Alzheimer’s disease drug trials. His other research interests include systematic reviews, population and public health from a life-course perspective, health policy and economics, and knowledge transfer.

Oliver Rivero-Arias, co-Editor-in-Chief

Dr Oliver Rivero-Arias is an Associate Professor at the Nuffield Department of Population Health (NDPH) at the University of Oxford. He is the Senior Health Economist at the National Perinatal Epidemiology Unit based in the NDPH and holds a DPhil in Public Health from the University of Oxford. His main research interests concern the use of robust and appropriate methods to measure and value costs and benefits for the conduct of economic evaluations of interventions during pregnancy, childbirth, the newborn period and early childhood. His research agenda focuses on developing best practices to measure and value health-related quality of life (HRQoL) in cost-effectiveness analysis and he currently leads a programme of work around valuing health to inform healthcare decision-making in child and adolescent populations.

Annual Journal Metrics